• 158 Citations
20132018
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2013 2018

2018

Anticoagulant drug choice in patients who have had bariatric surgery – Presently, DOACs are not the preferred choice

Moll, S. & Martin, K. A., Mar 1 2018, In : Thrombosis Research. 163, p. 196-199 4 p.

Research output: Contribution to journalEditorial

Bariatric Surgery
Anticoagulants
2017

Molecular basis of hemostatic and thrombotic diseases

Martin, K. A., Ma, A. D. & Key, N. S., Nov 2 2017, Molecular Pathology: The Molecular Basis of Human Disease. Elsevier Inc, p. 277-297 21 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hemostatics
Hemostasis
Thrombin
Hemophilia B
Thrombosis
3 Citations (Scopus)

Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension

Reilly, C. R., Babushok, D. V., Martin, K., Spivak, J. L., Streiff, M., Bahirwani, R., Mondschein, J., Stein, B., Moliterno, A. & Hexner, E. O., Sep 1 2017, In : American Journal of Hematology. 92, 9, p. 909-914 6 p.

Research output: Contribution to journalArticle

Transjugular Intrahepatic Portasystemic Shunt
Portal Hypertension
Neoplasms
Thrombosis
Primary Myelofibrosis
14 Citations (Scopus)

Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance

Martin, K. A., Lee, C. R., Farrell, T. M. & Moll, S., May 1 2017, In : American Journal of Medicine. 130, 5, p. 517-524 8 p.

Research output: Contribution to journalReview article

Bariatric Surgery
Anticoagulants
Pharmaceutical Preparations
International Normalized Ratio
Warfarin
6 Citations (Scopus)

Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis

Martin, K. A., Oct 1 2017, In : Current Hematologic Malignancy Reports. 12, 5, p. 389-396 8 p.

Research output: Contribution to journalReview article

Risk Management
Thrombosis
Hemorrhage
Neoplasms
Thrombocytosis
2016
13 Citations (Scopus)

Direct oral anticoagulant drug level testing in clinical practice: A single institution experience

Martin, K. & Moll, S., Jul 1 2016, In : Thrombosis Research. 143, p. 40-44 5 p.

Research output: Contribution to journalArticle

Anticoagulants
Outpatients
Pragmatic Clinical Trials
Hospital Emergency Service
Inpatients
21 Citations (Scopus)

How I treat patients with inherited bleeding disorders who need anticoagulant therapy

Martin, K. & Key, N. S., Jul 14 2016, In : Blood. 128, 2, p. 178-184 7 p.

Research output: Contribution to journalArticle

Anticoagulants
Hemorrhage
Atrial Fibrillation
Hemophilia B
von Willebrand Diseases
1 Citation (Scopus)

Lower doses of recombinant porcine factor VIII maintain excellent haemostatic efficacy

Martin, K., Kasthuri, R., Mooberry, M. J., Chen, S. L., Key, N. S. & Ma, A. D., Nov 1 2016, In : Haemophilia. 22, 6, p. e549-e551

Research output: Contribution to journalLetter

98 Citations (Scopus)

Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

Martin, K., Beyer-Westendorf, J., Davidson, B. L., Huisman, M. V., Sandset, P. M. & Moll, S., Jun 1 2016, In : Journal of Thrombosis and Haemostasis. 14, 6, p. 1308-1313 6 p.

Research output: Contribution to journalArticle

2014
2 Citations (Scopus)

Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes

Martin, K., Kia, L., Parikh, N. D., Kulik, L. & McMahon, B., Jan 1 2014, In : Annals of Hepatology. 13, 5, p. 548-554 7 p.

Research output: Contribution to journalArticle

Thrombocytopenia
Heparin
Fibrosis
Hematology
Survival Analysis
2013
Factor VII Deficiency
Off-Pump Coronary Artery Bypass
Factor VIIa
Recombinant Proteins
Coronary Artery Bypass